The property comprises the former AstraZeneca manufacturing facility; extending to a single unbroken brownfield redevelopment opportunity of approximately 100 acres (40.23 ha) gross*. The site is of a regular shape and has a flat topography, featuring a mix of offices, laboratories, manufacturing, and ancillary buildings, interspersed with large external concreted and tarmacadam areas. The buildings associated with the former use of the site remain in place.
( Agency Pilot Software Ref: 2043228 )